<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
81583-100-05
</NDCCode>
<PackageDescription>
5 BOTTLE, PLASTIC in 1 CARTON (81583-100-05) / 110 mL in 1 BOTTLE, PLASTIC
</PackageDescription>
<NDC11Code>
81583-0100-05
</NDC11Code>
<ProductNDC>
81583-100
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Ztalmy
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Ganaxolone
</NonProprietaryName>
<DosageFormName>
SUSPENSION
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20220606
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
NDA
</MarketingCategoryName>
<ApplicationNumber>
NDA215904
</ApplicationNumber>
<LabelerName>
Marinus Pharmaceuticals, Inc.
</LabelerName>
<SubstanceName>
GANAXOLONE
</SubstanceName>
<StrengthNumber>
50
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes>
GABA A Receptor Positive Modulators [MoA], Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]
</Pharm_Classes>
<DEASchedule>
CV
</DEASchedule>
<Status>
Deprecated
</Status>
<LastUpdate>
2024-05-15
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20241231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20220606
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>